Microscale diffusion immunoassay utilizing multivalent reactants
An improved microscale diffusion immunoassay utilizing multivalent reactants is disclosed. In particular, a method for detecting the presence of analyte particles in an analyte fluid is disclosed, the method comprising: (a) providing the analyte fluid comprising the analyte particles; (b) providing a diffusion fluid comprising binding particles capable of binding with the analyte particles; (c) flowing the analyte fluid and the diffusion fluid in adjacent laminar flow through a microfluidic channel; (d) allowing the analyte particles to diffuse into the diffusion fluid and bind with the binding particles to form analyte/binding particle complexes; and (e) detecting the presence of the analyte particles and the analyte/binding particle complexes, wherein each of the binding particles is capable of binding with more than one analyte particle, and wherein each of the analyte particles is capable of binding with more than one binding particle. Methods for determining the concentration of the analyte particles are also disclosed.
1. A method for detecting the presence of analyte particles in an analyte fluid comprising:
(a) providing the analyte fluid comprising the analyte particles;
(b) providing a diffusion fluid comprising binding particles capable of binding with the analyte particles;
(c) flowing the analyte fluid and the diffusion fluid in adjacent laminar flow through a microfluidic channel;
(d) allowing the analyte particles to diffuse into the diffusion fluid and bind with the binding particles to form analyte/binding particle complexes;
(e) allowing the analyte/binding particle complexes to cross-link to form cross-linked aggregates; and
(f) detecting the presence of the analyte particles and the cross-linked aggregates,
wherein:
each of the binding particles is capable of binding with more than one analyte particle;
each of the analyte particles is capable of binding with more than one binding particle;
the non-aggregated analyte/binding particle complexes and the analyte particles are at least the same order of magnitude in size and have diffusion coefficients that are essentially the same; and
the cross-linked aggregates have a diffusion coefficient that is at least two times greater than the diffusion coefficients of the non-aggregated analyte/binding particle complexes and the analyte particles.
2. The method of claim 1 , further comprising:
(g) detecting a diffusion profile in the microfluidic channel formed by the analyte particles and the cross-linked aggregates; and
(h) determining the concentration of the analyte particles.
3. The method of claim 2 wherein the concentration of analyte particles is determined based upon the diffusion profile of the analyte particles and cross-linked aggregates complexes.
4. The method of claim 2 wherein the concentration of analyte particles is determined by comparing the diffusion profile to a calibration profile.
5. The method of claim 1 wherein at least one of the analyte particles is labeled with a detectable marker.
6. The method of claim 1 wherein at least one of the binding particles is labeled with a detectable marker.
7. The method of claim 1 wherein the binding particles are antibodies.